Alpa Laboratories Limited (NSE:ALPA)

Market Cap	1.43B -31.3%
Revenue (ttm)	1.06B -5.9%
Net Income	150.10M -23.0%
EPS	n/a
Shares Out	21.04M
PE Ratio	9.55
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,735
Open	69.70
Previous Close	67.86
Day's Range	67.01 - 69.70
52-Week Range	46.10 - 108.30
Beta	0.95
Analysts	Strong Buy
Price Target	n/a
Earnings Date	May 29, 2026

About Alpa Laboratories

Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It provides formulations that address various therapeutic segments. The company was incorporated in 1988 and is based in Indore, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1988
• Employees: 453
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ALPA

Financial Performance

In fiscal year 2026, Alpa Laboratories's revenue was 1.06 billion, a decrease of -5.91% compared to the previous year's 1.12 billion. Earnings were 150.10 million, a decrease of -23.04%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error